Feasibility study of age-based propofol dosage calculation method in painless endoscopic digestive diagnosis and treatment

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300074069

Enrollment

Unknown

Registered

2023-07-28

Start date

2023-07-31

Completion date

Unknown

Last updated

2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless endoscopic digestive treatment

Interventions

control group:The dosage of propofol was calculated by body weight

experimental group:The dosage of propofol was calculated according to age

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients who choose to undergo painless gastroscopy; 2. Patients who choose to undergo painless colonoscopy 3. Patients who choose to undergo painless gastroscopy and colonoscopy

Exclusion criteria

Exclusion criteria: 1. Patients with severe liver and kidney dysfunction; 2. Mental and nervous system diseases; 3, hypertensive crisis, coronary heart disease untreated; 4, severe hearing and visual impairment, can not cooperate; 5. History of drug abuse or dependence; 6. Known allergy to the drug used.

Design outcomes

Primary

Measure	Time frame
pulse oxygen saturation;mean arterial pressure;Heart rate;awakening time;	—

Secondary

Measure	Time frame
the satisfaction of patients;	—

Countries

China

Contacts

Public ContactCan Yang

Nanjing Drum Tower Hospital

yangcan@njglyy.com+86 139 1292 9798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026